PMEF
OPRX icon

Point72 Middle East FZE’s OptimizeRx OPRX Stock Holding History

Point72 Middle East FZE’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,245
Closed -$32.8K – 1926
2023
Q1 		$32.8K Buy
2,245
+1,178
+110% +$19.7K ﹤0.01% 1348
2022
Q4 		$17.9K Buy
+1,067
New +$18.5K ﹤0.01% 1656

Other funds holding OPRX

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Point72 Middle East FZE's OPRX Position: Q2 2023 in Review

Point72 Middle East FZE sold out of OptimizeRx (OPRX) in Q2 2023, closing a stake of 2,245 shares — an estimated $32.8K sold.

Point72 Middle East FZE first reported a position in OPRX in Q4 2022 and held it in 2 quarters. The position peaked at $32.8K in Q1 2023. 102 funds tracked by Wall St. Rank hold OPRX as of Q2 2023.

  • Point72 Middle East FZE reported no remaining OptimizeRx position as of Q2 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 2,245 OptimizeRx shares in Q2 2023, an estimated $32.8K.
  • Point72 Middle East FZE first reported a position in OptimizeRx in Q4 2022 and held it in 2 quarters.
  • Point72 Middle East FZE's OptimizeRx position peaked at $32.8K in Q1 2023.
  • 102 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2023.

Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.